PCMN
MRK icon

Paradigm Capital Management (Nevada)’s Merck MRK Stock Holding History

Paradigm Capital Management (Nevada)’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.61M Sell
28,084
-2,385
-8% -$279K 3.1% 7
2026
Q1 		$3.67M Sell
30,469
-500
-2% -$57.7K 3.36% 7
2025
Q4 		$3.26M Buy
30,969
+280
+0.9% +$26.3K 3.03% 8
2025
Q3 		$2.58M Buy
30,689
+1,329
+5% +$109K 2.55% 11
2025
Q2 		$2.32M Buy
29,360
+3,740
+15% +$297K 2.3% 11
2025
Q1 		$2.3M Buy
25,620
+1,449
+6% +$135K 2.35% 10
2024
Q4 		$2.4M Buy
24,171
+1,056
+5% +$109K 2.25% 11
2024
Q3 		$2.63M Buy
+23,115
New +$2.75M 2.52% 10
2022
Q4 		$2.66M Sell
23,957
-49
-0.2% -$5.01K 3.89% 7
2022
Q3 		$2.07M Sell
24,006
-591
-2% -$52.8K 2.75% 8
2022
Q2 		$2.24M Sell
24,597
-49
-0.2% -$4.34K 2.82% 9
2022
Q1 		$2.02M Buy
24,646
+1,725
+8% +$136K 2.04% 13
2021
Q4 		$1.76M Buy
+22,921
New +$1.83M 1.75% 16

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Paradigm Capital Management (Nevada)'s MRK Position: Q2 2026 in Review

Paradigm Capital Management (Nevada) reduced its Merck (MRK) stake by 7.8% in Q2 2026, selling an estimated $279K and leaving 28,084 shares worth $3.61M. The position accounts for 3.1% of the portfolio, ranked #7.

Paradigm Capital Management (Nevada) first reported a position in MRK in Q4 2021 and has held it in 13 quarters since. The position peaked at $3.67M in Q1 2026. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Paradigm Capital Management (Nevada) held 28,084 shares of Merck worth $3.61M as of Q2 2026.
  • Paradigm Capital Management (Nevada) sold 2,385 Merck shares in Q2 2026, an estimated $279K.
  • Merck made up 3.1% of Paradigm Capital Management (Nevada)'s portfolio in Q2 2026, its #7 holding.
  • Paradigm Capital Management (Nevada) first reported a position in Merck in Q4 2021 and has held it in 13 quarters since.
  • Paradigm Capital Management (Nevada)'s Merck position peaked at $3.67M in Q1 2026.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Paradigm Capital Management (Nevada)'s 13F filing for Q2 2026, filed 14 Aug 2026.